Skip to main content

Day: November 6, 2023

Phyllis Turner-Brim Joins Adeia’s Board of Directors

SAN JOSE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) today announced that veteran intellectual property (IP) attorney and advisor, Phyllis Turner-Brim, joined Adeia’s board of directors on Friday, November 3, 2023. “Phyllis possesses an IP and business acumen that can only be gained through extensive experience. Her work in the world of intellectual property licensing, as well as her appointments as counsel for some of the largest and most respected corporations in the world, puts her in an ideal position to guide and advise Adeia’s leadership team toward its strategic objectives,” said Paul E. Davis, chief executive officer of Adeia. “Her impressive track record of achievement stems from a keen understanding of IP honed in senior executive roles with major enterprises, including Starbucks and HP, and IP...

Continue reading

IntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with Tilray

IntelGenx to Manufacture and Supply Three New Filmstrip Products: CBD20, THC10, and THC10:CBD10 SAINT LAURENT, Quebec, Nov. 06, 2023 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that it and Tilray Brands Inc. (“Tilray”) have entered into a further amendment (the “Second Amendment”) to their November 2018 license, development and supply agreement for the co-development and commercialization of cannabinoid-infused VersaFilm® products, settling IntelGenx’s arbitration claim against Tilray. Pursuant to the Second Amendment, IntelGenx has received an initial purchase order from Tilray for three SKUs (CBD20, THC10, THC10:CBD 10), with each SKU totalling 130,000 filmstrips. The Second Amendment also allows for IntelGenx’s co-development and commercialization...

Continue reading

Acceleware Awarded $3 Million in Non-Dilutive Funding from The Clean Resource Innovation Network

Additional Funding for RF XL Commercial-Scale PilotElectrical HouseE-house at Acceleware’s RF XL Commercial-Scale Pilot Test at Marwayne, AB. July 2023CALGARY, Alberta, Nov. 06, 2023 (GLOBE NEWSWIRE) — Acceleware Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of transformative technologies targeting the decarbonization of industrial heating, is pleased to announce an agreement for $3 million in non-dilutive grant funding with the Clean Resource Innovation Network (“CRIN”). The funding will be applied to eligible project costs incurred between January 1, 2022 and March 31, 2024 for the commercial-scale pilot of RF XL at Marwayne, Alberta (“the Pilot”). CRIN’s funding is intended to accelerate clean technology development and commercialization for oil and gas industry challenges, and is made...

Continue reading

Foresight: Eye-Net and SoftBank Corp. Successfully Complete First Phase of Cross-Collision Prevention V2X Project in Japan

The second phase of the project includes deployment of Eye-Net’s location service in SoftBank’s 5G Multi-Access Edge Computing infrastructure Ness Ziona, Israel, Nov. 06, 2023 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd. (“Eye-Net” or “Eye-Net Mobile”), announced the successful completion of the first phase of a multi-phase project with SoftBank Corp. (Tokyo: 9434) (“SoftBank”). SoftBank confirmed the successful completion of the initial phase of the multi-phase project. We believe that this progress indicates an important step in the collaboration between SoftBank and Eye-Net. SoftBank is anticipating Eye-Net’s deployment of its innovative location service within SoftBank’s...

Continue reading

ArcelorMittal S.A.: ArcelorMittal announces the publication of its third quarter 2023 sell-side analyst consensus figures

6 November 2023, 14:10 CET ArcelorMittal today announces the publication of its third quarter 2023 sell-side analysts’ consensus figures. The consensus figures are based on analysts’ estimates recorded on an external web-based tool provided and managed by an independent company, Visible Alpha. To arrive at the consensus figures below, Visible Alpha has aggregated the expectations of sell-side analysts who, to the best of our knowledge, cover ArcelorMittal on a continuous basis. The listed analysts follow ArcelorMittal on their own initiative and ArcelorMittal is not responsible for their views. ArcelorMittal is neither involved in the collection of the information nor in the compilation of the estimates. 3Q’23 consensus estimatesEBITDA ($m)                       $1,815 Net income ($m)                  $909 Earnings per share ($)         $1.10Number...

Continue reading

ExactCare and Tabula Rasa HealthCare Business Combination Closes, Creating a Leading, Independent Value-Based Pharmacy Management Company for Patients with the Most Complex Needs

CLEVELAND, Nov. 06, 2023 (GLOBE NEWSWIRE) — ExactCare®, a national provider of medication management and comprehensive long-term pharmacy services and a Nautic Partners portfolio company, today announced that the acquisition of Tabula Rasa HealthCare, Inc.®, a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, is complete. ExactCare and Tabula Rasa are creating a leading, independent pharmacy care management company that specializes in caring for the most at-risk patient populations in the healthcare system—helping them to live healthier and thrive in both home- and community-based settings. Together, the two organizations care for over 100,000 beneficiaries served by the Program of All-Inclusive Care for the Elderly (PACE), Medicare, Medicaid and Dual-eligible plans. “This...

Continue reading

BellRing Brands’ Executive Chairman Rob Vitale to Take Medical Leave of Absence

ST. LOUIS, Nov. 06, 2023 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today announced that its Executive Chairman, Robert V. Vitale, will be taking an unexpected medical leave of absence, which was also announced by Post Holdings, Inc. At this time, it is too soon to know the course of treatment and timing of recovery. On behalf of the management team and board of directors of BellRing, “Our thoughts and best wishes are with Rob and his family as he recovers.” About BellRing Brands, Inc. BellRing Brands, Inc. is a rapidly growing leader in the global convenient nutrition category offering ready-to-drink shake and powder protein products. Its primary brands, Premier Protein® and Dymatize®, appeal to a broad range of consumers and are distributed...

Continue reading

OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical

WARSAW, Ind., Nov. 06, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the Company has entered into an exclusive Distribution Agreement with Ora Medical, based in Montreal, to sell Ora Medical’s gait trainer, The Levity, a device designed for children with walking difficulties. The Levity supports a child with an innovative partial weight bearing mechanism. This allows the child to interact with the world using their arms, unlocking tons of possibilities. Its unique design allows each child to receive a personalized treatment. The Levity comes with versatile features to meet a wide range of needs: body weight support, harness, speed and direction of the device are adjustable, and its foldable design offers...

Continue reading

Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that it will host a conference call and live audio webcast on Monday, November 13, 2023 at 4:30 p.m. ET to report its third quarter 2023 financial results and provide an update on its business and pipeline. To access the call, please dial 1-877-704-4453 (domestic) or 1-201-389-0920 (international) and refer to conference ID 13741831, or click on this link and request a return call. The audio webcast can be accessed on the “Events and Presentations” page under the “Connect” tab of the Company’s...

Continue reading

CommScope and STMicroelectronics make Matter provisioning for IoT devices secure and easy

ST CommScope Matter collaborationST CommScope Matter collaborationCommScope and STMicroelectronics make Matter provisioningfor IoT devices secure and easy Integrated solution of PKIWorks platform with STM32WB wireless microcontroller enables IoT security for Matter device development Claremont, N.C., Geneva, Switzerland – November 6, 2023 – CommScope (NASDAQ: COMM), a global leader in network connectivity,   and STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced today the integration of CommScope’s PKIWorks™ IoT security platform with ST’s popular STM32WB microcontroller unit (MCU). This integrated solution offers device manufacturers a turnkey solution for developing IoT devices that meet the Connectivity Standards Alliance Matter standard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.